Your browser doesn't support javascript.
loading
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.
Herbrich, Shelley; Baran, Natalia; Cai, Tianyu; Weng, Connie; Aitken, Marisa J L; Post, Sean M; Henderson, Jared; Shi, Chunhua; Richard-Carpentier, Guillame; Sauvageau, Guy; Baggerly, Keith; Al-Atrash, Gheath; Davis, R Eric; Daver, Naval; Zha, Dongxing; Konopleva, Marina.
Afiliação
  • Herbrich S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Weng C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Aitken MJL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Post SM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Henderson J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shi C; Oncology Research for Biologics and Immunotherapy Translation (ORBIT) platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Richard-Carpentier G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sauvageau G; University of Montreal Institute for Research in Immunology and Cancer, Montreal, Quebec, Canada.
  • Baggerly K; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zha D; Oncology Research for Biologics and Immunotherapy Translation (ORBIT) platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mkonople@mdanderson.org.
J Immunother Cancer ; 9(7)2021 07.
Article em En | MEDLINE | ID: mdl-34326171
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antígenos CD / Evasão da Resposta Imune Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antígenos CD / Evasão da Resposta Imune Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article